Common painkillers increase risk of heart problems: StudyJanuary 12th, 2011 - 1:13 pm ICT by ANI
Washington, Jan 12 (ANI): A new study has associated common painkillers to increased risk of heart problems.
The drugs include traditional non-steroidal anti-inflammatory drugs (NSAIDS) as well as new generation anti-inflammatory drugs, known as COX-2 inhibitors.
NSAIDs have been the cornerstone of managing pain in patients with osteoarthritis and other painful conditions.
So researchers in Switzerland performed a comprehensive analysis of all randomised controlled trials comparing any NSAID with other NSAIDs or placebo.
They included 31 trials and 116,429 patients taking seven different drugs (naproxen, ibuprofen, diclofenac, celecoxib, etoricoxib, rofecoxib, lumiracoxib) or placebo to provide a more reliable estimate of the cardiovascular risks of these drugs than previous studies.
Overall, the number of harmful outcomes that could be compared for placebo versus treatment was low.
In 29 trials there was a total of 554 heart attacks; in 26 trials there were 377 strokes, and in 28 trials there were 676 deaths. So the absolute risk of cardiovascular problems among people taking painkillers was low, but the researchers did find that, relative to placebo, the drugs carried important risks.
For instance, compared with placebo, rofecoxib and lumiracoxib were associated with twice the risk of heart attack, while ibuprofen was associated with more than three times the risk of stroke.
Etoricoxib and diclofenac were associated with the highest risk of cardiovascular death.
Naproxen appeared least harmful in terms of cardiovascular safety among the seven analysed preparations. (ANI)
- Painkillers double risk of miscarriage: Study - Sep 07, 2011
- Painkillers could kill heart attack survivors early - Sep 11, 2012
- Painkillers shoot up death risk in heart attacks - May 10, 2011
- Ibuprofen could treble stroke risk - Jan 12, 2011
- Topical treatments offer effective local pain relief - Jun 16, 2010
- New aspirin curbs 11 kinds of cancer, shrinks tumours - Mar 09, 2012
- Widely used arthritis pill shows promise against skin cancer - Dec 03, 2010
- Ibuprofen more effective than paracetamol for period pain - Jan 20, 2010
- Aspirin, ibuprofen offer no protection against skin cancer - Feb 16, 2010
- Ibuprofen may reduce risk of Parkinson's disease - Mar 03, 2011
- Ibuprofen painkillers cut risk of dying among elderly - Jul 08, 2010
- Anti-depressants ease osteoarthritis pain - Mar 23, 2012
- Ginkgo Biloba extracts could treat pain, inflammation - Apr 28, 2011
- Painkillers overuse causing a million headaches in Britain - Sep 19, 2012
- 'Ibuprofen promotes bone healing post fracture' - Jul 04, 2012
Tags: absolute risk, anti inflammatory drugs, cardiovascular death, cardiovascular problems, cardiovascular risks, cox 2 inhibitors, diclofenac, etoricoxib, heart attack, heart attacks, heart problems, lumiracoxib, naproxen, non steroidal anti inflammatory drugs, nsaid, nsaids, osteoarthritis, randomised controlled trials, risk of heart attack, rofecoxib